Chennai-based Orchid Pharma Ltd has informed the BSE that the company has received the Establishment Inspection Report (EIR) from the US Food and Drug Administration (USFDA) based on the successful inspection closure for the formulation manufacturing facility located at Irungattukottai, near Chennai. The facility was inspected by USFDA in May 2015.
Orchid Pharma gets inspection report
Published on
December 31, 2015 17:17